Vanderbilt Health News Archive — Page 286 of 390

syringe
September 19, 2013

VU testing vaccine against new flu threat

Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring.

September 19, 2013

Photo: Building support

Representatives from longtime supporter Balfour Beatty Construction visited the Medical Center recently to present an additional gift in support of the existing Balfour Beatty Research Fund for Personalized Cancer Medicine.

September 19, 2013

Ultrasound Section of Radiology receives AIUM re-accreditation

The Ultrasound Section of Vanderbilt’s Department of Radiology recently received maximum length re-accreditation through the American Institute of Ultrasound in Medicine, the largest ultrasound organization in the world.

September 19, 2013

Study tracks clot removal’s effectiveness at treating stroke

Over the past decade, neurointerventionalists have refined techniques for manually removing blood clots causing stroke. Now they are joining forces for a clinical trial to demonstrate the safety and effectiveness of the techniques.

September 18, 2013

Free online course on data management for clinical research now underway

Vanderbilt University’s latest offering on the online learning platform Coursera, “Data Management for Clinical Research,” went live this week. More than 33,000 number of students have registered for the massive open online course or MOOC.

September 12, 2013

VU tracking drug’s ability to prevent type 1 diabetes

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.